Classification of Psychiatric Disorders

Psychiatric disorders are often grouped together based on their similarities, which can be useful for research and classification purposes. The three main clusters are eccentric, dramatic, and fearful. The eccentric cluster includes paranoid, schizoid, and schizotypal disorders. The dramatic cluster includes borderline, narcissistic, antisocial, and histrionic disorders. The fearful cluster includes obsessive-compulsive, avoidant, and dependent disorders.

The classification of psychiatric disorders follows the operational criteria of either DSM or ICD. DSM-V, published by the American Psychiatric Association, is multi-axial and allows for assessment of the patient’s current mental state diagnosis, personality disorder and learning difficulties, any physical condition, psychosocial or environmental factors, and global assessment of functioning scale. On the other hand, ICD-10, published by the World Health Organization, is used widely in Europe and also includes a multi-axial approach. However, personality disorder is not differentiated from other mental state disorders in ICD. The three axes in ICD are current mental state diagnosis (including personality disorder), disabilities, and contextual factors.

In summary, the classification of psychiatric disorders is important for research and treatment purposes. The three main clusters of disorders are eccentric, dramatic, and fearful. DSM and ICD are the two main operational criteria used for classification, with DSM being multi-axial and including a global assessment of functioning scale, while ICD is also multi-axial but does not differentiate personality disorder from other mental state disorders.

Citalopram works by selectively inhibiting the reuptake of serotonin, while atomoxetine inhibits the reuptake of norepinephrine. Modafinil acts as a dopamine reuptake inhibitor, and methylphenidate inhibits the reuptake of both norepinephrine and dopamine. Haloperidol is an example of an antipsychotic medication.

In March 2018, NICE released new guidelines for the recognition and management of Attention Deficit Hyperactivity Disorder (ADHD). This condition can have a significant impact on a child’s life and can continue into adulthood, making accurate diagnosis and treatment crucial. ADHD is defined by DSM-V as a persistent condition that includes features of inattention and/or hyperactivity/impulsivity, with an element of developmental delay. The threshold for diagnosis is six features for children up to 16 years old and five features for those aged 17 or over. ADHD has a prevalence of 2.4% in the UK, with a possible genetic component and a higher incidence in boys than girls.

NICE recommends a holistic approach to treating ADHD that is not solely reliant on medication. After presentation, a ten-week observation period should follow to determine if symptoms change or resolve. If symptoms persist, referral to secondary care is necessary, usually to a paediatrician with a special interest in behavioural disorders or to the local Child and Adolescent Mental Health Service (CAMHS). A tailored plan of action should be developed, taking into account the patient’s needs and wants and how their condition affects their lives.

Drug therapy should be considered a last resort and is only available to those aged 5 years or older. For patients with mild/moderate symptoms, parents attending education and training programmes can be beneficial. For those who fail to respond or have severe symptoms, pharmacotherapy can be considered. Methylphenidate is the first-line treatment for children and should be given on a six-week trial basis. Lisdexamfetamine can be used if there is an inadequate response, and dexamfetamine can be started in those who have benefited from lisdexamfetamine but cannot tolerate its side effects. In adults, methylphenidate or lisdexamfetamine are first-line options, with switching between drugs if no benefit is seen after a trial of the other.

All of these drugs have the potential to be cardiotoxic, so a baseline ECG should be performed before starting treatment. Referral to a cardiologist is necessary if there is any significant past medical history or family history, or any doubt or ambiguity. A thorough history and clinical examination are essential for accurate diagnosis, given the overlap of ADHD with many other psychiatric and physical conditions.

Metabolic alkalosis, hypokalemia, and hypochloremia are commonly observed in individuals with bulimia nervosa, even if their BMI falls within a normal range. This is due to the excessive self-induced vomiting, which results in the loss of stomach acid (HCl) and potassium.

Understanding Bulimia Nervosa

Bulimia nervosa is an eating disorder that is characterized by recurrent episodes of binge eating followed by purging behaviors such as self-induced vomiting, misuse of laxatives, diuretics, or other medications, fasting, or excessive exercise. According to the DSM 5 diagnostic criteria, individuals with bulimia nervosa experience a sense of lack of control over eating during the episode, and the binge eating and compensatory behaviors occur at least once a week for three months. Recurrent vomiting may lead to erosion of teeth and Russell’s sign – calluses on the knuckles or back of the hand due to repeated self-induced vomiting.

Individuals with bulimia nervosa are unduly influenced by body shape and weight, and their self-evaluation is often based on these factors. It is important to note that the disturbance does not occur exclusively during episodes of anorexia nervosa. Referral for specialist care is appropriate in all cases, and NICE recommends bulimia-nervosa-focused guided self-help for adults. If this approach is not effective, individual eating-disorder-focused cognitive behavioral therapy (CBT-ED) may be considered. Children should be offered bulimia-nervosa-focused family therapy (FT-BN). While pharmacological treatments have a limited role, a trial of high-dose fluoxetine is currently licensed for bulimia, but long-term data is lacking.

In summary, bulimia nervosa is a serious eating disorder that requires specialized care. Early intervention and treatment can help individuals recover and improve their quality of life.

Weight gain is a prevalent side effect of antipsychotics.

While antipsychotics are successful in treating schizophrenia, they often lead to weight gain and an increased likelihood of developing type 2 diabetes. The most rapid weight gain typically occurs within the first six months of starting antipsychotic treatment.

In particular, Olanzapine and Clozapine are associated with a high risk of weight gain. They stimulate appetite and result in overeating, as well as disrupt glucose regulation.

Schizophrenia management guidelines were published by NICE in 2009. The guidelines recommend that first-line treatment for schizophrenia should involve oral atypical antipsychotics. Additionally, cognitive behavioural therapy should be offered to all patients. It is important to pay close attention to cardiovascular risk-factor modification due to the high rates of cardiovascular disease in schizophrenic patients, which is linked to antipsychotic medication and high smoking rates. Therefore, healthcare professionals should take necessary measures to reduce the risk of cardiovascular disease in these patients.

Defense Mechanisms: Coping Strategies for Unacceptable Emotions

Defense mechanisms are psychological strategies that individuals use to cope with unacceptable emotions and thoughts. These mechanisms are often unconscious and can be helpful in managing difficult situations. One such mechanism is sublimation, which involves channeling negative emotions into more acceptable outlets. For example, a person who is angry may choose to engage in physical exercise as a way to release their emotions.

Another defense mechanism is displacement, which involves transferring emotions from one person or situation to another. This can be seen when a person who is angry with their boss comes home and takes out their frustration on their family members. Intellectualization is another mechanism that allows individuals to focus on the facts of a situation rather than the emotions they are feeling. This can be helpful in situations where emotions may be overwhelming, such as when dealing with a serious illness.

Rationalization is a defense mechanism that allows individuals to justify their behavior in a logical manner when their ego is threatened. For example, a student who fails an exam may blame the teacher rather than accepting responsibility for their own actions. Finally, denial is a mechanism that involves consciously avoiding painful topics. This can be seen when a patient denies being told that they have a serious illness.

Overall, defense mechanisms can be helpful in managing difficult emotions and situations. However, it is important to recognize when these mechanisms are being used and to seek help if they are interfering with daily life.

Individuals with a history of alcohol or drug abuse and deliberate self harm, particularly males, should be considered at high risk for suicide.

The risk of suicide in psychiatric patients is often stratified into high, medium, or low risk categories, but there is limited evidence on the positive predictive value of individual risk factors. A review in the BMJ concluded that these assessments may not be useful in guiding decision making, as 50% of suicides occur in patients deemed low risk. However, certain factors have been associated with an increased risk of suicide, such as male sex, history of deliberate self-harm, alcohol or drug misuse, mental illness, depression, schizophrenia, chronic disease, advancing age, unemployment or social isolation, and being unmarried, divorced, or widowed.

If a patient has attempted suicide, there are additional factors that increase the risk of completed suicide in the future, such as efforts to avoid discovery, planning, leaving a written note, final acts such as sorting out finances, and using a violent method. On the other hand, there are protective factors that can reduce the risk of suicide, such as having family support, having children at home, and having a religious belief.

Understanding Ego Defenses

Ego defenses are psychological mechanisms that individuals use to protect themselves from unpleasant emotions or thoughts. These defenses are classified into four levels, each with its own set of defense mechanisms. The first level, psychotic defenses, is considered pathological as it distorts reality to avoid dealing with it. The second level, immature defenses, includes projection, acting out, and projective identification. The third level, neurotic defenses, has short-term benefits but can lead to problems in the long run. These defenses include repression, rationalization, and regression. The fourth and most advanced level, mature defenses, includes altruism, sublimation, and humor.

Despite the usefulness of understanding ego defenses, their classification and definitions can be inconsistent and frustrating to learn for exams. It is important to note that these defenses are not necessarily good or bad, but rather a natural part of human behavior. By recognizing and understanding our own ego defenses, we can better manage our emotions and thoughts in a healthy way.

The patient had auditory hallucinations and a delusion that he was being spied on for 6 months, indicating a diagnosis of schizophrenia. The psychiatrist likely prescribed an antipsychotic, which can cause prolonged QT interval and require electrocardiograms. Galactorrhea, a common side effect of antipsychotics like risperidone, olanzapine, or quetiapine, occurs because the medication inhibits dopamine, which usually suppresses prolactin release. The patient did not initially report symptoms of a prolactinoma and was correctly diagnosed with schizophrenia. The relief of dopamine inhibition on prolactin release is the cause of antipsychotic-induced galactorrhea. While schizophrenia patients may develop endocrine disorders, this is not the best explanation for a patient experiencing known side effects of medication. If galactorrhea persists or worsens after stopping the medication, referral to an endocrinologist may be necessary. The patient’s well-controlled condition and the presence of galactorrhea indicate a medication side effect, and worsening would manifest as an increase in positive or negative symptoms.

Antipsychotics are a type of medication used to treat schizophrenia, psychosis, mania, and agitation. They are divided into two categories: typical and atypical antipsychotics. The latter were developed to address the extrapyramidal side-effects associated with the first generation of typical antipsychotics. Typical antipsychotics work by blocking dopaminergic transmission in the mesolimbic pathways through dopamine D2 receptor antagonism. However, they are known to cause extrapyramidal side-effects such as Parkinsonism, acute dystonia, akathisia, and tardive dyskinesia. These side-effects can be managed with procyclidine. Other side-effects of typical antipsychotics include antimuscarinic effects, sedation, weight gain, raised prolactin, impaired glucose tolerance, neuroleptic malignant syndrome, reduced seizure threshold, and prolonged QT interval. The Medicines and Healthcare products Regulatory Agency has issued specific warnings when antipsychotics are used in elderly patients due to an increased risk of stroke and venous thromboembolism.

Types of Delusions

Grandiose delusions are a type of delusion where the individual has an inflated sense of self-importance. They believe that they are related to a higher figure, such as a deity, a monarch, or a celebrity. They may also believe that they possess great wealth, power, or social status. These delusions are commonly seen in individuals with bipolar disorder during manic episodes, as well as in other psychotic disorders.

On the other hand, erotomanic delusions are a type of delusion where the individual believes that someone of a higher social status is in love with them. This type of delusion can be dangerous, as the individual may become obsessed with the object of their delusion and may engage in stalking or other inappropriate behaviors.

The young girl in question appears to be suffering from anorexia nervosa, as she is overly concerned with her weight despite having a low body mass index. It is common for females of a young age to develop this condition, and it is often accompanied by depression, which can manifest as low mood, loss of interest in hobbies, and sleep disturbances.

One recommended antidepressant for patients with anorexia nervosa is mirtazapine, as it can also increase appetite and promote weight gain. Fluoxetine, a selective serotonin reuptake inhibitor, is not contraindicated for anorexia nervosa, but it can cause gastrointestinal distress or sexual dysfunction, which may make it difficult for young patients to comply with the medication. Amitriptyline, a tricyclic antidepressant, is typically used for major depression but has a worse side-effect profile than selective serotonin reuptake inhibitors. Bupropion, an atypical antidepressant commonly used for smoking cessation, is not recommended for patients with anorexia nervosa or bulimia nervosa, as it can lower the seizure threshold and increase the risk of seizures.

Selective serotonin reuptake inhibitors (SSRIs) are the first-line treatment for depression, with citalopram and fluoxetine being the preferred options. They should be used with caution in children and adolescents, and patients should be monitored for increased anxiety and agitation. Gastrointestinal symptoms are the most common side-effect, and there is an increased risk of gastrointestinal bleeding. Citalopram and escitalopram are associated with dose-dependent QT interval prolongation and should not be used in certain patients. SSRIs have a higher propensity for drug interactions, and patients should be reviewed after 2 weeks of treatment. When stopping a SSRI, the dose should be gradually reduced over a 4 week period. Use of SSRIs during pregnancy should be weighed against the risks and benefits.